Downregulation of CDH13 expression promotes invasiveness of bladder transitional cell carcinoma

Urologia Internationalis

Volumn 90, Issue 2, 2013, Pages 225-232

  Lin, Ying Li ^a   He, Zheng Kai ^b   Li, Zhi Gang ^c   Guan, Tong Yu ^a  

^a Xuzhou Tumor Hospital (Xuzhou Third People's Hospital)   (China)

^b SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

^c General Hospital of CNPC in Jilin   (China)

Author keywords

Bladder cancer; CDH13; Invasion

Indexed keywords

CADHERIN; CDH13 PROTEIN; GELATINASE A; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; EPITHELIUM; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METHYLATION; RNA INTERFERENCE; TRANSITIONAL CELL CARCINOMA; WESTERN BLOTTING;

CADHERINS; CARCINOMA, TRANSITIONAL CELL; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION; URINARY BLADDER NEOPLASMS;

EID: 84874485394     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000345054     Document Type: Article

References (26)

1. Ploeg M, Aben KK, Kiemeney LA: The present and future burden of urinary bladder cancer in the world. World J Urol 2009; 27: 289-293
2. Van Rhijn BW, Burger M, Lotan Y, Solsona E, Stief CG, Sylvester RJ, Witjes JA, Zlotta AR: Recurrence and progression of disease in non-muscle-invasive bladder cancer: From epidemiology to treatment strategy. Eur Urol 2009; 56: 430-442
3. Jacobs BL, Lee CT, Montie JE: Bladder cancer in 2010: How far have we come? CA Cancer J Clin 2010; 60: 244-272
4. Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, Schoenberg MP, Lerner SP: Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: A contemporary series from the Bladder Cancer Research Consortium. J Urol 2006; 176: 2414-2422
5. Morgan TM, Clark PE: Bladder cancer. Curr Opin Oncol 2010; 22: 242-249
6. Andreeva AV, Kutuzov MA: Cadherin 13 in cancer. Genes Chromosomes Cancer 2010; 49: 775-790
7. Philippova M, Joshi MB, Kyriakakis E, Pfaff D, Erne P, Resink TJ: A guide and guard: The many faces of T-cadherin. Cell Signal 2009; 21: 1035-1044
8. Yu J, Zhu T, Wang Z, Zhang H, Qian Z, Xu H, Gao B, Wang W, Gu L, Meng J, Wang J, Feng X, Li Y, Yao X, Zhu J: A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer. Clin Cancer Res 2007; 13: 7296-7304
9. Maruyama R, Toyooka S, Toyooka KO, Harada K, Virmani AK, Zöchbauer-Müller S, Farinas AJ, Vakar-Lopez F, Minna JD, Sagalowsky A, Czerniak B, Gazdar AF: Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. Cancer Res 2001; 61: 8659-8663
10. Lin YL, Liu XQ, Li WP, Sun G, Zhang CT: Promoter methylation of H-cadherin is a potential biomarker in patients with bladder transitional cell carcinoma. Int Urol Nephrol 2012; 44: 111-117
11. Mao Q, Li Y, Zheng X, Yang K, Shen H, Qin J, Bai Y, Kong D, Jia X, Xie L: Up-regulation of E-cadherin by small activating RNA inhibits cell invasion and migration in 5637 human bladder cancer cells. Biochem Biophys Res Commun 2008; 375: 566-570
12. Swiatkowski S, Seifert HH, Steinhoff C, Prior A, Thievessen I, Schliess F, Schulz WA: Activities of MAP-kinase pathways in normal uroepithelial cells and urothelial carcinoma cell lines. Exp Cell Res 2003; 282: 48-57
13. Adachi Y, Takeuchi T, Nagayama T, Furihata M: T-cadherin modulates tumor-associated molecules in gallbladder cancer cells. Cancer Invest 2010; 28: 120-126
14. Alameh M, Jean M, Dejesus D, Buschmann MD, Merzouki A: Chitosanase-based method for RNA isolation from cells transfected with chitosan/siRNA nanocomplexes for real-time RT-PCR in gene silencing. Int J Nanomed 2010; 5: 473-481
15. Shen A, Zhang Y, Yang H, Xu R, Huang G: Overexpression of ZEB1 relates to metastasis and invasion in osteosarcoma. J Surg Oncol 2012; 105: 830-834
16. Wang B, Xu YF, He BS, Pan YQ, Zhang LR, Zhu C, Qu LL, Wang SK: RNAi-mediated silencing of CD147 inhibits tumor cell proliferation, invasion and increases chemosensitivity to cisplatin in SGC7901 cells in vitro. J Exp Clin Cancer Res 2010; 29: 61
17. Chen RX, Xia YH, Xue TC, Ye SL: Transcription factor c-Myb promotes the invasion of hepatocellular carcinoma cells via increasing osteopontin expression. J Exp Clin Cancer Res 2010; 29: 172
18. Golubovskaya VM, Zheng M, Zhang L, Li JL, Cance WG: The direct effect of focal adhesion kinase (FAK), dominant-negative FAK, FAK-CD and FAK siRNA on gene expression and human MCF-7 breast cancer cell tumorigenesis. BMC Cancer 2009; 9: 280
19. Lin Y, Sun G, Liu X, Chen Y, Zhang C: Clinical significance of T-cadherin tissue expression in patients with bladder transitional cell carcinoma. Urol Int 2011; 86: 340-345
20. Martin TA, Mason MD, Jiang WG: Tight junctions in cancer metastasis. Front Biosci 2011; 16: 898-936
21. Moh MC, Shen S: The roles of cell adhesion molecules in tumor suppression and cell migration: A new paradox. Cell Adh Migr 2009; 3: 334-336
22. Riou P, Saffroy R, Chenailler C, Franc B, Gentile C, Rubinstein E, Resink T, Debuire B, Piatier-Tonneau D, Lemoine A: Expression of T-cadherin in tumor cells influences invasive potential of human hepatocellular carcinoma. FASEB J 2006; 20: 2291-2301
23. Mukoyama Y, Zhou S, Miyachi Y, Matsuyoshi N: T-cadherin negatively regulates the proliferation of cutaneous squamous carcinoma cells. J Invest Dermatol 2005; 124: 833-838
24. Huang ZY, Wu Y, Hedrick N, Gutmann DH: T-cadherin-mediated cell growth regulation involves G2 phase arrest and requires p21(CIP1/WAF1) expression. Mol Cell Biol 2003; 23: 566-578
25. Gritsenko PG, Ilina O, Friedl P: Interstitial guidance of cancer invasion. J Pathol 2012; 226: 185-199
26. Mohammad MA, Ismael NR, Shaarawy SM, El-Merzabani MM: Prognostic value of membrane type 1 and 2 matrix metalloproteinase expression and gelatinase A activity in bladder cancer. Int J Biol Markers 2010; 25: 69-74